QuickView for CYP1B1;jsessionid=3953E34A356F416CB15FC0085D20B0B2;jsessionid=441CB592D30380133B1A85C7A58C4C10;jsessionid=BBBBE266CB599B83A339245279B9C094;jsessionid=8691D19BFE3AAECBD67335B69C385E1C (gene)

1. Variable Phenotype of Congenital Corneal Opacities in Biallelic CYP1B1 Pathogenic Variants.
2. Development of novel N-aryl-2,4-bithiazole-2-amine-based CYP1B1 degraders for reversing drug resista…
3. Lower overall survival in male patients with advanced disease undergoing allogeneic hematopoietic st…
4. 17-(R/S)-hydroxyeicosatetraenoic acid (HETE) induces cardiac hypertrophy through the CYP1B1 in enant…
5. Design of Novel 2-Phenylquinazolin-4-amines as Selective CYP1B1 Inhibitors for Overcoming Paclitaxel…

There were no clinical trials for CYP1B1;jsessionid=3953E34A356F416CB15FC0085D20B0B2;jsessionid=441CB592D30380133B1A85C7A58C4C10;jsessionid=BBBBE266CB599B83A339245279B9C094;jsessionid=8691D19BFE3AAECBD67335B69C385E1C